PSB
VRTX icon

Piscataqua Savings Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Piscataqua Savings Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10
Closed -$3.92K – 410
2025
Q3 		$3.92K Hold
10
– – ﹤0.01% 322
2025
Q2 		$4.45K Buy
+10
New +$4.61K ﹤0.01% 321

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Piscataqua Savings Bank's VRTX Position: Q4 2025 in Review

Piscataqua Savings Bank sold out of Vertex Pharmaceuticals (VRTX) in Q4 2025, closing a stake of 10 shares — an estimated $3.92K sold.

Piscataqua Savings Bank first reported a position in VRTX in Q2 2025 and held it in 2 quarters. The position peaked at $4.45K in Q2 2025. 1,668 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

  • Piscataqua Savings Bank reported no remaining Vertex Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Piscataqua Savings Bank sold 10 Vertex Pharmaceuticals shares in Q4 2025, an estimated $3.92K.
  • Piscataqua Savings Bank first reported a position in Vertex Pharmaceuticals in Q2 2025 and held it in 2 quarters.
  • Piscataqua Savings Bank's Vertex Pharmaceuticals position peaked at $4.45K in Q2 2025.
  • 1,668 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Piscataqua Savings Bank's 13F filing for Q4 2025, filed 16 Jan 2026.